# Vaxcyte, Inc. (PCVX) - Q2 2026 earnings

Reported August 5, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | $12.5M |
| EPS | $-1.97 | $-2.06 |

Earnings filing reader: [8-K 0001649094-26-000041](https://www.opencapital.sh/filings/0001649094-26-000041)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001649094-26-000041.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000041/0001649094-26-000041-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1649094/000164909426000043/0001649094-26-000043-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/pcvx/earnings/q2-2026
